| Course | PHLT 8331 Fundamentals of Biostatistics |
|---|---|
| Week | Week 1 |
| Paper type | Discussion post |
| Length | About 530 words, 3 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for PHLT 8331 Week 1
Week 1 Discussion: Initial Post and Replies
A Registry of Every Warfarin Patient at Three Clinics Is Not Every Warfarin Patient: What a Statistic From a Composite Anticoagulation Registry Can Estimate
Initial Post
The dataset I will use this term is a composite registry of 1,140 adults taking warfarin at three community health center clinics. Warfarin requires regular blood tests of the international normalized ratio, or INR, and the registry records each patient's INR results, from which it calculates the share of time each patient spends in the target range, a measure called time in therapeutic range, using the linear interpolation method described by Rosendaal et al. (1993). The registry feels as if it speaks for everyone on warfarin. It does not, and the difference determines what any statistic computed from it can estimate.
Three populations are worth separating. The target population is the group a reader would like to learn about, perhaps all adults on warfarin in the region or the country. The source population is the group from which the registry actually drew: adults on warfarin who receive care at these three clinics. The registry itself is the source population's patients during the years it has operated, minus those whose records are incomplete. Every statistic I compute will describe the registry directly and, with care, the source population. Its findings carry over to warfarin users in general only as far as these clinics' patients resemble them, and they may not: community health center patients are more often uninsured or covered by Medicaid, and the clinics share particular staffing and testing routines.
Size does not solve this, a point introductory texts make when they separate the population of interest from the population sampled (Pagano et al., 2022). A registry of 1,140 patients gives precise estimates for its own source population, but precision about the wrong population is not accuracy about the right one. A small random sample from the target population could tell me more about it than a large registry that drew from somewhere else.
That does not make the registry useless. It is well suited to questions about these clinics, such as whether a pharmacist-led anticoagulation service introduced at two of them is associated with better control. Reviews of such services in other settings have found better anticoagulation control than routine medical care in most studies (Manzoor et al., 2017), which gives a reason to ask the question here.
For the group: what population does your dataset draw from, and what population do you want to talk about?
Reply to Simone
Simone, your dataset of students who completed a campus health survey is large, but it includes only those who chose to respond. Your statistics describe respondents well. Would comparing respondents with the campus enrollment on age and year help you judge how far they speak for all students?
Reply to Andre
Andre, you described your county's cancer registry as a census of all cases, which makes its source and target populations nearly the same for cancer incidence in the county. That is a real strength. It would weaken if your question were about all residents' cancer risk factors, which the registry does not record. Which question will you ask of it?
References
Manzoor, B. S., Cheng, W.-H., Lee, J. C., Uppuluri, E. M., & Nutescu, E. A. (2017). Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: A systematic review. Annals of Pharmacotherapy, 51(12), 1122-1137. https://doi.org/10.1177/1060028017721241
Pagano, M., Gauvreau, K., & Mattie, H. (2022). Principles of biostatistics (3rd ed.). CRC Press.
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993). A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69(3), 236-239. https://doi.org/10.1055/s-0038-1651587
The Walden PHLT 8331 Week 1 instructions
Opening threads in introductory biostatistics usually ask students to introduce the dataset they will analyze and explain what population its statistics can describe. Faculty want the population a study is about kept apart from the population that supplied the data, with a frank account of where the two may part ways. Calculations are not the point this week; reasoning about inference is. A brief description of the main outcome helps classmates follow later posts. Plan on roughly five hundred words supported by two or three sources, one of them on how the outcome is measured. Two replies should help classmates locate their own datasets in the same framework and suggest a way to check how far the data generalize.
How this PHLT 8331 Week 1 example is built
The post introduces the registry, its INR records and the time in therapeutic range measure, citing the interpolation method used to compute it. A paragraph defines the target, source and registry populations and explains how community health center patients might differ from all warfarin users. A paragraph argues that sample size does not fix a mismatch between source and target, citing an introductory biostatistics text. A paragraph explains what the registry is well suited for, citing a review of pharmacist-managed anticoagulation. The post ends by asking classmates something. The reply to Simone suggests comparing survey respondents with campus enrollment. The reply to Andre notes that a cancer registry's census of cases is a strength for incidence questions but not for risk factor questions. Margin notes mark the distinctions that carry the post's argument.
PHLT 8331 Week 1 rubric: what earns full marks
Strong scores on this thread come from conceptual clarity. The sample earns them by separating three populations and explaining what each statistic computed from the registry can and cannot estimate. Recognizing that a large sample can be precise about the wrong population shows understanding that many first posts miss. Graders verify that the outcome measure is described correctly and that each source says what the post claims. Replies are credited when they apply the framework to a classmate's data and propose a concrete check, such as comparing respondents with a known population. Writing clearly, posting on schedule and citing in APA style supply the smaller rubric points. Naming the registry's strengths for clinic-level questions, rather than dismissing it, also earns credit for balance.
Common PHLT 8331 Week 1 mistakes, and how to avoid them
First posts in statistics courses often describe a dataset's size and variables without asking whom its results describe. Name the population you care about and the one your data came from, then say how they might differ. Resist the idea that a large dataset is automatically representative; precision and representativeness are different properties. Keep the outcome description short and accurate. In replies, avoid general praise; help classmates see their own source population and suggest a way to test generalizability. No calculations are needed yet. We can write a post like this one around your own dataset, and your first sample costs nothing.
Get a PHLT 8331 Week 1 example written to your instructions
Share the Week 1 discussion prompt and rubric, and mention the dataset or example your section uses. The post comes with two replies extending the idea to classmates' examples, delivered within 24-48h, the first at no cost. Its registry is composite, and the populations it names illustrate reasoning rather than describing any real clinic.
More PHLT 8331 papers and PhD in Public Health samples
- PHLT 8331 Week 2: Variable Distribution Brief
- PHLT 8331 Week 3: Hypothesis Statement Paper
- PHLT 8331 Week 4: Paired t-Test Write-Up
- PHLT 8331 Week 5: Two-Group Mean Comparison
- PHLT 8331 Week 6: Test Condition Peer Replies
- PHLT 8331 Week 7: Chi-Square and McNemar Tests
- PHLT 8331 Week 8: ANOVA With Trend Contrast
- PHLT 8331 Week 9: Confidence Interval Interpretation
- PHLT 8331 Week 10: Effect Size Decision Brief
- PHLT 8331 Week 11: Plain-Language Findings Report
- PHLT 8270 Week 1: Surveillance Coverage Post
- PHLT 8078 Week 1: Jurisdiction Gap Discussion Post
- PHLT 8076 Week 1: Map Question Orientation Post
- PHLT 8074 Week 1: Exposure Framing Discussion Post
PHLT 8331 Week 1 questions, answered
Where can I find a free PHLT 8331 Week 1 sample paper?
Below sits the whole Week 1 thread, starting with a main post about what a composite anticoagulation registry can and cannot estimate, plus two replies applying the same reasoning to classmates' data, with notes on why each part works.
Is a large registry the same as a representative sample?
No. A registry can be large and still drawn from a particular source population, such as patients at a few clinics. Its size makes estimates precise for that population but does not make them accurate for a broader one.
How does a target population differ from a source population?
The target population is the group you want to learn about. The source population is the group your data were actually drawn from. Statistics describe the source population directly and the target only as far as the two resemble each other.
Should the concept post include calculations?
Usually not. The first week focuses on reasoning about populations and inference. The sample describes its dataset and outcome but leaves calculations for later weeks, when the methods they require are introduced.
What is time in therapeutic range?
It is the percentage of time a patient taking warfarin has a blood test result, the INR, within the target range, commonly 2.0 to 3.0. It is often estimated by interpolating between test dates and is widely used to judge anticoagulation control.